PEDONE, CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 10.978
NA - Nord America 4.800
EU - Europa 2.140
SA - Sud America 759
AF - Africa 129
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.851
Nazione #
SG - Singapore 7.325
US - Stati Uniti d'America 4.594
CN - Cina 1.571
HK - Hong Kong 1.196
IT - Italia 961
BR - Brasile 555
GB - Regno Unito 401
VN - Vietnam 329
FR - Francia 290
DE - Germania 136
IN - India 136
BD - Bangladesh 114
CA - Canada 110
AR - Argentina 77
NL - Olanda 55
ID - Indonesia 54
MX - Messico 54
ZA - Sudafrica 46
ES - Italia 41
PL - Polonia 40
AU - Australia 39
TR - Turchia 37
EC - Ecuador 35
UA - Ucraina 34
FI - Finlandia 33
JP - Giappone 29
IQ - Iraq 28
CO - Colombia 23
PK - Pakistan 23
IR - Iran 19
PH - Filippine 19
SA - Arabia Saudita 19
MA - Marocco 17
CL - Cile 16
RU - Federazione Russa 16
LT - Lituania 15
SE - Svezia 15
VE - Venezuela 15
CZ - Repubblica Ceca 12
TN - Tunisia 12
PY - Paraguay 11
RS - Serbia 11
BG - Bulgaria 10
PE - Perù 10
UY - Uruguay 10
EG - Egitto 9
CR - Costa Rica 8
KE - Kenya 8
KZ - Kazakistan 8
MD - Moldavia 8
NP - Nepal 8
IL - Israele 7
MY - Malesia 7
AT - Austria 6
BE - Belgio 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
AL - Albania 5
DZ - Algeria 5
EE - Estonia 5
IE - Irlanda 5
JM - Giamaica 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
KR - Corea 4
NI - Nicaragua 4
PT - Portogallo 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
DK - Danimarca 3
HN - Honduras 3
JO - Giordania 3
KY - Cayman, isole 3
LU - Lussemburgo 3
PA - Panama 3
RO - Romania 3
SN - Senegal 3
TJ - Tagikistan 3
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CM - Camerun 2
GE - Georgia 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
LY - Libia 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
QA - Qatar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
Totale 18.813
Città #
San Jose 1.698
Hong Kong 1.192
Singapore 1.080
Ashburn 1.059
Rome 712
Hefei 596
Boardman 346
London 344
Beijing 262
Lauterbourg 246
Shanghai 205
Dallas 185
Ho Chi Minh City 111
Hanoi 77
Los Angeles 76
Council Bluffs 74
New York 74
San Francisco 68
Santa Clara 63
São Paulo 51
Munich 47
Pune 42
Washington 37
Toronto 36
Seattle 32
Warsaw 30
Mexico City 29
Orem 27
Amsterdam 26
West Jordan 26
Rio de Janeiro 25
Brooklyn 24
Montreal 24
Milan 23
Boston 21
Chicago 21
Turku 21
Da Nang 19
Haiphong 19
Johannesburg 19
Tokyo 19
Guangzhou 18
Atlanta 17
Canberra 17
Chennai 16
Biên Hòa 15
Buffalo 15
Guayaquil 14
Frankfurt am Main 13
Paris 13
Manchester 12
Melbourne 12
Quito 12
Charlotte 11
Helsinki 11
Baghdad 10
Lahore 10
Phoenix 10
Porto Alegre 10
Stockholm 10
Ankara 9
Calgary 9
Dhaka 9
Montevideo 9
Mumbai 9
Riyadh 9
Salvador 9
Shenzhen 9
Zhengzhou 9
Bari 8
Belgrade 8
Belo Horizonte 8
Brno 8
Markham 8
Bogotá 7
Caracas 7
Florence 7
Lima 7
Madrid 7
Nairobi 7
Nuremberg 7
Bologna 6
Bình Dương 6
Curitiba 6
Guarulhos 6
Houston 6
Jakarta 6
Manaus 6
Osasco 6
Ribeirão Preto 6
San José 6
Sydney 6
Turin 6
Ahmedabad 5
Asunción 5
Bauru 5
Brasília 5
Buenos Aires 5
Campinas 5
Changsha 5
Totale 9.609
Nome #
A decision support system for tele-monitoring copd-related worrisome events 267
A Novel Interplay Between Irisin and PTH: From Basic Studies to Clinical Evidence in Hyperparathyroidism 259
Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey 236
Migrants rescued on the Mediterranean Sea route: nutritional, psychological status and infectious disease control 228
Bone Quality as Measured by Trabecular Bone Score in Normocalcemic Primary Hyperparathyroidism 225
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 224
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 221
Is Citicoline Effective in Preventing and Slowing Down Dementia?—A Systematic Review and a Meta-Analysis 218
Agreement between equations estimating glomerular filtration rate in elderly nursing home residents and in hospitalised patients: implications for drug dosing 217
ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study 214
Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD 213
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 211
Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes 209
Computed tomography highlights increased visceral adiposity associated with critical illness in covid-19 208
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths 204
A rare cause of chronic diarrhoea in an elderly patient 199
Treating COPD in Older and oldest old Patientsp 181
Asthma in the elderly: mortality rate and associated risk factors for mortality 181
Predictors of undernutrition in COPD patients 179
Relationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary disease 175
Non-invasive ventilation in octuagenarians out of the intensive care unit: Tolerability, efficacy and safety results 171
"Cardiovascular dementia" reappraisal of an old concept and Giambattista Vico's course and recourse theory: is history repeating itself? 155
25(OH) vitamin D and functional outcomes in older adults admitted to rehabilitation units: the safari study 153
Accuracy of spirometry in diagnosing pulmonary restriction in elderly people 150
CLINICAL, BIOCHEMICAL AND RADIOLOGICAL PROFILE OF NORMOCALCAEMIC HYPERPARATHYROIDISM: A MULTICENTRIC CROSS-SECTIONAL EVALUATION 148
Increased carotid thickness in subjects with recently-diagnosed diabetes from rural Cameroon 145
Ageing and COPD affect different domains of nutritional status: the ECCE study 142
Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System 139
Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic: Did age make the difference? 137
An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial 134
Association of reduced total lung capacity with mortality and use of health services 133
BIONOTE e-nose technology may reduce false positives in lung cancer screening programmes 128
CARDIOVASCULAR AUTONOMIC NEUROPATHY CAUSES AN IMPAIRMENT OF QUALITY OF LIFE IN SUBJECTS WITH CHRONIC HYPOPARATHYROIDISM 128
Agreement between Chronic Kidney Disease Epidemiological Collaboration and Berlin Initiative Study equations for estimating glomerular filtration rate in older people: The Invecchiare in Chianti (Aging in Chianti Region) study 126
BODE index or geriatric multidimensional assessment for the prediction of very-long-term mortality in elderly patients with chronic obstructive pulmonary disease? A prospective cohort study 125
Alternative ways of expressing forced expiratory volume in the first second and long-term mortality in elderly patients with asthma 122
Age does not hamper the response to pulmonary rehabilitation of COPD patients 121
Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency 120
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 119
Adiponectin and bone mass density The InCHIANTI study 119
The Oxygen therapy 116
Authors' Reply to Brunetti et al. "Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?" 115
Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism 114
Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) 114
Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism 107
Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients 107
Pre-polysomnographic assessment using the Pittsburgh Sleep Quality Index questionnaire is not useful in identifying people at higher risk for obstructive sleep apnea 105
Association between frailty index, lung function, and major clinical determinants in chronic obstructive pulmonary disease 103
Risk Factors for Fragility Fractures in Type 1 Diabetes 101
Genetic background of idiopathic pulmonary fibrosis 101
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength 100
Cardiovascular Autonomic Neuropathy as a New Complication of Postsurgical Chronic Hypoparathyroidism 99
Effects of different masks on diaphragm motion in OSAS patients undergoing CPAP: results from an ultrasound-based proof of concept study 97
Noninvasive ventilation in older adults admitted to a pneumogeriatric unit 96
Use of Plant-Derived Natural Products in Sleep Disturbances 94
Energy expenditure and intake in COPD: The extent of unnoticed unbalance by predicting REE 92
Is it time to use pre-bronchodilator spirometry to rule out COPD? 89
Age and severe adverse drug reactions caused by nifedipine and verapamil. Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA) 88
Patients with migraine with aura have increased flow mediated dilation 87
Dementia, osteoporosis and fragility fractures: Intricate epidemiological relationships, plausible biological connections, and twisted clinical practices 85
Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions 84
Curcumin use in pulmonary diseases: State of the art and future perspectives 66
Utility of an electronic nose in discriminating obstructive sleep apnea and COPD by breath fingerprints analysis 66
Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial 65
Association between PUFA intake and serum concentration and mortality in older adults: A cohort study 64
Nursing student attitudes towards older people: validity and reliability of the Italian version of the Kogan Attitudes towards Older People scale 62
PTH(1-34) for surgical hypoparathyroidism: A 2-year prospective, open-label investigation of efficacy and quality of life 62
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 61
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 61
Validation of FEV6 in the elderly: correlates of performance and repeatability 61
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 61
Effect of insulin resistance on BMD and fracture risk in older adults 59
PTH(1-34) for the primary prevention of postthyroidectomy hypocalcemia: The THYPOS trial 59
Integration of voltammetric analysis, protein electrophoresis and pH measurement for diagnosis of pleural effusions: a non-conventional diagnostic approach 59
Non-invasive monitoring of lower-limb ulcers via exudate fingerprinting using BIONOTE 59
On the remote detection of COPD-related worrisome events 58
Hemoglobin concentration influences N-terminal Pro B-type natriuretic peptide levels in hospitalized older adults with and without heart failure 58
GOLD and the fixed ratio Response 57
Association between sodium excretion and cardiovascular disease and mortality in the elderly: a cohort study 57
Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study) 57
Chronic obstructive pulmonary disease in the elderly 56
Clusters of functional domains to identify older persons at risk of disability 56
Body mass index and mortality among hospitalized patients 56
Health status in older hospitalized patients with cancer or non-neoplastic chronic diseases 56
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 56
Correlates of mortality in elderly COPD patients: focus on health related quality of life 56
Cardiac amyloidosis awareness among residents/specialists in geriatrics: An italian national survey 55
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 55
Chronic renal failure: a neglected comorbidity of COPD 55
Nutritional status is associated with physical function and disability in older adults with chronic heart failure 55
Are Performance Measures Necessary to Predict Loss of Independence in Elderly People? 55
Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People 54
Systematic review of telemonitoring in COPD: an update 54
Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women 54
Effects of topical therapy on the breath pattern of patients with newly diagnosed COPD: An e-nose based study 54
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 54
Endothelial dysfunction in chronic obstructive pulmonary disease. 53
Exhaled breath analysis by electronic nose in respiratory diseases 53
Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease 52
Predicting survival of older community-dwelling individuals according to five estimated glomerular filtration rate equations: The InChianti study 52
Totale 11.321
Categoria #
all - tutte 142.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022378 0 5 17 0 10 1 2 9 12 8 5 309
2022/2023147 15 5 3 7 7 7 15 5 5 3 75 0
2023/20241.074 45 127 36 83 111 455 11 51 37 37 44 37
2024/20258.654 150 101 385 55 79 237 132 46 815 742 2.667 3.245
2025/20268.684 853 341 514 1.027 343 541 2.383 730 745 778 354 75
Totale 18.937